<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>bolar exemption on Turklegal IP - Turkish Patent and Trademark Attorneys</title><link>https://turklegal.com.tr/en/tags/bolar-exemption/</link><description>Recent content in bolar exemption on Turklegal IP - Turkish Patent and Trademark Attorneys</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Tue, 02 Jun 2026 18:31:40 +0300</lastBuildDate><atom:link href="https://turklegal.com.tr/en/tags/bolar-exemption/index.xml" rel="self" type="application/rss+xml"/><item><title>Bolar Exemption, Data Exclusivity and Patent Term Extensions in Türkiye</title><link>https://turklegal.com.tr/en/insights/bolar-exemption-data-exclusivity-patent-term-extensions-turkiye/</link><pubDate>Tue, 02 Jun 2026 10:00:00 +0300</pubDate><author>T. Yazici</author><guid>https://turklegal.com.tr/en/insights/bolar-exemption-data-exclusivity-patent-term-extensions-turkiye/</guid><description>&lt;h2 id="introduction"&gt;Introduction&lt;/h2&gt;
&lt;p&gt;The development and commercialization of pharmaceutical products require substantial investments in research, testing, clinical trials and regulatory approvals. In addition to patent protection, pharmaceutical innovators may benefit from regulatory mechanisms designed to protect the data generated during the authorization process.&lt;/p&gt;</description></item></channel></rss>